Introduction
The superficial spreading type of early gastric carcinoma (SSEGC) is characterized by a wide, superficial vant therapy, in the affiliated hospitals of Niigata University between 1992 and 1998. The average age of the seven patients (four men; three women) at the time of surgery was 71.0 years. All resected specimens were fixed in 10% formalin immediately after resection. The entire lesion was serially cut into 4-to 5-mm-thick pieces. Samples were embedded in paraffin. In all cases, immunohistochemistry (IHC) and DNA analysis were conducted. Lymph node metastasis had occurred in two patients, and specimens were available for IHC and DNA analysis (Table 2) . Histological examination was performed based on the Japanese Research Society for Gastric Cancer classification of gastric carcinoma [16] . Using the system of classification of Watanabe et al. [17] , we divided carcinomas into two groups, according to histological and cytological atypia: low-grade carcinoma (L), and high-grade carcinoma (H).
Immunohistochemical analysis of p53 protein
Three serial, 3-µm-thick sections were made from all blocks of each carcinoma. The first section was stained with hematoxylin and eosin (H&E), the second section was immunostained for p53, using the mouse monoclonal antibody PAb1801 (Oncogene Science I, Manhasset, NY, USA), and the third section was immunostained for Ki-67 (MIB1; Immunotech, Marseille, France). Immunohistochemical staining was performed using streptavidin-peroxidase complex. We used Ki-67 staining as the inner control to prove the adequacy of immunoreactivity, observing nonneoplastic proliferative cells in the neck zone or the germinal center cells of lymph follicles. In the total of seven cases, 80 lesions were analyzed for the p53 protein.
p53-Positive cells were defined as those with brownstained nuclei, regardless of the staining intensity. Expression of p53 protein was classified into four categories: (1) (ϩϩϩ), positive cells distributed throughout most of the lesion; (2) (ϩϩ), positive cells aggregated in focal area(s); (3) (ϩ), a small number of isolated positive cells were scattered in the lesion; and (4) (Ϫ), negative. Overexpression of p53 was defined as (ϩϩϩ) or (ϩϩ), according to a published study [18] .
DNA preparation
We selected representative sections of carcinoma not only by depth but also by differences in p53 staining patterns and histological and cytological atypia. Six to 14 lesions in each tumor (60 in total) were sampled as mucosal carcinomas, and 2 to 5 lesions from each tumor (20 in total) were sampled as submucosal carcinomas.
DNA extraction from paraffin sections was performed as follows: tissue sections from five to ten serial, nonstained 10-µm-thick sections from each sample were dewaxed in xylene for 10 min and rehydrated in 99% ethanol for 5 min. The lesions were dissected under direct observation with a microscope to avoid contamination of noncarcinoma cells, using commercially available sterilized disposable 25-G ϫ 1Љ needles (Φ 0.5 mm) (Terumo, Tokyo, Japan). There were around 3500-7000 cells, including at least 80% carcinoma cells, used in each sample; every sample was selected using a DNA isolator PS kit (Wako, Osaka, Japan). DNA was precipitated successively with isopropyl alcohol and with 99% ethanol and was then dried. Samples were then dissolved in 30 µl of sterile water.
Polymerase chain reaction (PCR)
Oligonucleotide primers were synthesized by Takara Shuzo (Kyoto, Japan). Four fragments of DNA, including exons 5-8 of p53, were amplified, using nested PCR with two sets of primers for each exon. The first and second PCR amplification primers were described previously [19] . The first PCR was performed using a 50-µl reaction mixture containing 50 mM potassium chloride, 10 mM Tris-HCl (pH 8.0), 0.1% Triton X-100, 1.5 mM magnesium chloride, 200 µM of each nucleotide (dATP, dCTP, dGTP, dTTP (Takara Shuzo), 20 pM of each primer, 2.5 units of Taq DNA polymerase (Promega, Madison, WI, USA), and 1 or 2 µl of DNA template. One cycle was performed at 94°C for 5 min, 55°C for 1 min and 30 s, and 72°C for 1 min; followed by 35 cycles at 94°C for 1 min, 60°C for 1 min 30 s, and 72°C for 1 min; and finally, a 7-min extension at 72°C, using the Program Temp Control System (ASTEC; Fukuoka, Japan). The product of the first PCR was used as the template for the second PCR, which was performed under the same conditions; however, during the second PCR, one primer in each set was biotinylated at the 5Ј terminal (Takara Shuzo). In each experiment, control reactions containing no DNA samples or human placental DNA (Oncogene Science; Uniondale, NY, USA) were performed simultaneously with the sample reactions. The products of the second PCR were electrophoresed for 20 min on 4% agarose gel (NuSieve 3: 1 Agarose; FMC BioProducts, Rockland, ME, USA) using a Mermaid Kit from Bio101 (La Jolla, CA, USA). Informative cases were defined as those with amplified bands on the agarose gels.
Direct sequencing
All products of the second PCR were sequenced directly, using an Auto Load Solid Sequencing Kit (Pharmacia Biotech, Uppsala, Sweden) and an automated laser fluorescent sequencer (ALF DNA Sequencer II; Pharmacia). The same oligonucleotides as inner PCR primers were labeled fluorescently at their 5Ј terminals (Takara Shuzo) and used as sequencing primers. To confirm the findings, we analyzed all samples at least twice, in both the sense and antisense directions, using different PCR products obtained from the same samples.
Results
We detected seven different kinds of p53 mutations: one in exon 5, two in exon 7, and four in exon 8; no mutations were detected in exon 6. All the mutations were transitional mutations, and three occurred in CpG dinucleotide pairs. Point mutations of codon 248 (CGG to CAG) and codon 273 (CGT to CAT) were commonly observed in two different cases (Table 2) .
We found heterogeneity of p53 gene alterations in mucosal carcinoma lesions in three (cases 1 to 3) of the seven cases (Table 2) . In case 1, we discovered 8 mucosal carcinoma lesions with four different p53 mutational patterns: 6 lesions occurred with a single mutational pattern (codon 248 or 258, or 273) and 2 lesions appeared without mutations through exons 5 to 8 (Figs. 1, 2) . In case 2, we identified 10 mucosal carcinoma lesions with four different p53 mutational patterns: 4 lesions appeared with a single mutational pattern (codon 282), 1 with double mutations (codons 282 and 153), and 1 with triple mutations (codons 282, 278, and 300); 4 lesions without mutations through exons 5 to 8 were also observed. In case 3, there were 14 mucosal carcinoma lesions: 12 lesions with a same single mutation (codon 248) and 2 lesions were without mutations through exons 5 to 8. Two other cases (cases 4 and 5) showed a heterogeneous p53 immunostaining pattern in the mucosal carcinomas, but no gene alteration was detected. There were three lesions with p53 protein overexpression and four without overexpression in case 4, and two lesions with overexpression and four without overexpression in case 5. Two other cases (cases 6 and 7) showed identical p53 mutations in each tumor; both of them were immunohistochemical and gene alterations.
In all cases, the submucosal carcinoma showed a homogeneous mutational status that was identical to one of the mucosal mutations in the same tumor.
We also analyzed four lesions identified among the lymph node metastases, (one lesion from case 5, and three lesions from case 7). No mutations were found in exons 5 through 8 in case 5, and the same mutation (codon 273) as in the primary carcinoma was found in case 7.
Most lesions with a (Ϫ) or (ϩ) pattern for p53 immunostaining (21 of 22; 95.5%) did not show any (Table  2) .
Discussion
p53 Mutation is reported to be the most commonly implicated genetic event in gastric carcinogenesis [13] ; it is also an early event that is often observed in differentiated types of gastric carcinoma [7, 13] . Sequencing of the p53 gene in mammals has revealed five highly conserved domains, four of which fall within exons 5 through 8, where most of the evolutionarily conserved amino acids are concentrated [20] . Most of the mutations occur within exons 5 through 8, which we have analyzed in this study. We assessed mutations in the p53 gene by direct sequencing, because single-strand polymorphism analysis often fails to predict p53 mutational status [21] . We found seven different kinds of mutations, all of which were transitional mutations; some of these mutations occurred at the CpG site. In gastric carcinoma, base transitions were thought to be the most frequent type of genetic change in the p53 gene [6] . Our findings suggest that, even in SSEGCs, base transitions are common genetic alterations, as are those observed in other types of gastric carcinoma. CpG dinucleotides in the p53 gene seem to be a primary target for mutations associated with dietary carcinogens such as the Nnitroso compounds [22] .
Bamba et al. [23] have reported that most SSEGCs are monoclonal; their methodology included using polymorphisms of the X-linked human androgen receptor gene (HUMARA) methods. They examined eight informative cases, and only one case showed heterogeneity. It should be noted that their report did not clarify from which layers the carcinoma cells had been microdissected. In some cases, the number of the lesions examined was small. Thus there remains the possibility that the number of polyclonal cases could be higher than the number they reported. In addition, their study focused on gastric cancers that manifested at least some signet ring cells. In contrast, we focused on gastric cancers that mainly contained well differentiated carcinoma glands. Indeed, there are some differences between these two types of carcinoma. For example, the location of the proliferative zones is different [24] , the premalignant lesions differ [25] , and some genetic abnormalities differ as well [13, 26] . Therefore, we inferred that the clonality of gastric cancinomas might differ according to the dominant histological types.
Three reasons are posited to explain why p53 heterogeneity was found in mucosal carcinomas. The first is based on the "field cancerization" theory. SSEGCs may be derived from the collision of different small gastric carcinomas. In many SSEGCs, we found a number of histological types and various kinds of cytological atypia; these findings support this reason for p53 heterogeneity in the mucosal carcinomas. The second possible reason is that p53 mutation occurred within a single tumor after clonal expansion. In case 2, we found the same mutation in codon 282 (CGG to TGG) in six mucosal carcinoma lesions; two of these lesions showed other additional mutation(s) in codon 282 ( Table 2) . The third reason is a combination of the two former explanations.
Kang et al. [27] reported 12 heterogeneous cases of synchronous multiple gastric carcinoma, using p53, MCC, and APC gene analysis. They also suggested that the theory of field cancerization could help to explain gastric carcinogenesis. Further research needs to be done to analyze other genes in order to clarify the clonality of gastric carcinoma. Cho et al. [28] analyzed heterogeneity by means of p53 gene alterations, and showed that there was no correlation between histological type and p53 mutations. In regard to this point, there is no discrepancy between their results and ours.
It should also be noted that there was no p53 heterogeneity in layers deeper than that of the muscularis mucosae carcinomas. In all cases, the submucosal carcinoma showed a homogeneous mutational status that was identical to that of the mucosal mutations in the same tumor. The p53 mutation must have occurred in the mucosal carcinoma, preceding the submucosal invasion, in some SSEGCs. In the mucosal carcinoma lesions, there was a combination of high-and low-grade carcinoma cells, while, in contrast, all of the submucosal carcinoma lesions showed high-grade atypia. We have reported that cells with high-grade atypia in carcinoma readily invade the submucosal layer. We suggest the possibility that a clone with high-grade atypia was selected from among multiple clones within the mucosal carcinoma, and subsequently invaded the submucosal layer.
We examined seven cases of SSEGCs because large carcinoma cells remained in the mucosal layer. But in almost all of the cases, except for cases 5 and 6, a small number of carcinoma cells were found in the invasive lesions. In the future, we hope to analyze more cases with a larger number of carcinoma cells from both mucosaosal and invasive lesions. In order to clarify the p53 clonality of gastric carcinoma, similar analysis regarding early invasive carcinomas, other than SSEGC, needs to be done.
In conclusion, p53 heterogeneity was determined in many cases of SSEGC. It is highly possible that gastric carcinoma cells arise polyclonally during the intramucosal carcinoma stage, and that they later develop into monoclonal populations, while invading the submucosal layer, through clonal selection, with respect to the p53 gene alteration.
